CGM (not implantable version) - significant reduction in HbA1c in patients with baseline HbA1c over 53 mmol/mol (7%), severe hypoglycaemia reduced by 45%
CGM (ບໍ່ແມ່ນຮຸ່ນທີ່ສາມາດປູກໄດ້) - ການຫຼຸດລົງຢ່າງຫຼວງຫຼາຍໃນ HbA1c ໃນຄົນເຈັບທີ່ມີ HbA1c ພື້ນຖານໃນໄລຍະ 53 mmol / mol (7%), hypoglycaemia ຮ້າຍແຮງຫຼຸດລົງ 45%